Rubius Therapeutics, Inc.

2023 Q1 Form 10-K Financial Statement

#000170940123000005 Filed on February 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.90M $14.87M
YoY Change -93.4% -93.42%
Cash & Equivalents $14.90M $14.87M
Short-Term Investments $0.00
Other Short-Term Assets $5.330M $5.330M
YoY Change 34.09% 34.09%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.20M $20.20M
YoY Change -91.21% -91.21%
LONG-TERM ASSETS
Property, Plant & Equipment $146.0K $2.825M
YoY Change -99.72% -96.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $50.00K $50.00K
YoY Change -96.82% -96.82%
Total Long-Term Assets $2.875M $2.875M
YoY Change -96.74% -96.74%
TOTAL ASSETS
Total Short-Term Assets $20.20M $20.20M
Total Long-Term Assets $2.875M $2.875M
Total Assets $23.07M $23.07M
YoY Change -92.75% -92.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.232M $1.232M
YoY Change -89.35% -89.35%
Accrued Expenses $4.409M $4.409M
YoY Change -80.33% -80.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $7.939M $7.939M
YoY Change -77.09% -77.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.939M $7.939M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $7.939M $7.939M
YoY Change -94.3% -94.3%
SHAREHOLDERS EQUITY
Retained Earnings -$856.7M
YoY Change 26.54%
Common Stock $90.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.13M $15.13M
YoY Change
Total Liabilities & Shareholders Equity $23.07M $23.07M
YoY Change -92.75% -92.75%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001709401
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List
DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#RestructuringCostsAndAssetImpairmentCharges
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-38586
CY2022 dei Entity Registrant Name
EntityRegistrantName
RUBIUS THERAPEUTICS, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2688109
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Verdolino & Lowey, P.C.
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
124 Washington Street,
CY2022 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 101
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Foxborough,
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02035
CY2022 dei City Area Code
CityAreaCode
(508)
CY2022 dei Local Phone Number
LocalPhoneNumber
543-1720
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022 dei Trading Symbol
TradingSymbol
RUBY
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
28400000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90397732 shares
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
584800000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
583600000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
37200000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
547600000 usd
CY2022 dei Auditor Firm
AuditorFirmId
238
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2022 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14865000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225848000 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
4070000 usd
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 ruby Prepaid Expense And Other Current
PrepaidExpenseAndOtherCurrent
1260000 usd
CY2021Q4 ruby Prepaid Expense And Other Current
PrepaidExpenseAndOtherCurrent
3975000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
20195000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
229823000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2679000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
35095000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
146000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
135000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51530000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1573000 usd
CY2022Q4 us-gaap Assets
Assets
23070000 usd
CY2021Q4 us-gaap Assets
Assets
318021000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1232000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11572000 usd
CY2022Q4 ruby Accrued Expenses And Other Current Liabilities Excluding Current Operating Lease Liabilities
AccruedExpensesAndOtherCurrentLiabilitiesExcludingCurrentOperatingLeaseLiabilities
5607000 usd
CY2021Q4 ruby Accrued Expenses And Other Current Liabilities Excluding Current Operating Lease Liabilities
AccruedExpensesAndOtherCurrentLiabilitiesExcludingCurrentOperatingLeaseLiabilities
14072000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1100000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9015000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7939000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34659000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
76154000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28291000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7939000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
139239000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90387732 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90387732 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90063770 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90063770 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
90000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
90000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
871725000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
855710000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-856684000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-677018000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15131000 usd
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1283000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
178782000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23070000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
318021000 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2020 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96414000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
141587000 usd
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
116107000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30835000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53029000 usd
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50341000 usd
CY2022 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
51197000 usd
CY2021 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2020 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
178446000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
194616000 usd
CY2020 us-gaap Operating Expenses
OperatingExpenses
166448000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-178446000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-194616000 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-166448000 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
819000 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
91000 usd
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1760000 usd
CY2022 us-gaap Interest Expense
InterestExpense
3863000 usd
CY2021 us-gaap Interest Expense
InterestExpense
6434000 usd
CY2020 us-gaap Interest Expense
InterestExpense
4185000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1824000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4412000 usd
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1142000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1220000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1931000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-179666000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-196547000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-167731000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.99
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.23
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.23
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.08
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.08
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90305463 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90305463 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87950440 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87950440 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80624608 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80624608 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-179666000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-196547000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-167731000 usd
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 usd
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-71000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-179666000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-196551000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-167802000 usd
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
274213000 usd
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1484000 usd
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33665000 usd
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-71000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-167731000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
141560000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
800000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
187200000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10685000 usd
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
278000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
0 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35610000 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-196547000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
178782000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
98000 usd
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
134000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
0 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15783000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-179666000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15131000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-179666000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-196547000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-167731000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
15783000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
35610000 usd
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
33665000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6254000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7723000 usd
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5691000 usd
CY2022 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
305000 usd
CY2021 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-118000 usd
CY2020 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-266000 usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
604000 usd
CY2021 us-gaap Other Noncash Expense
OtherNoncashExpense
1280000 usd
CY2020 us-gaap Other Noncash Expense
OtherNoncashExpense
349000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-25841000 usd
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1128000 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2738000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1249000 usd
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-992000 usd
CY2022 ruby Increase Decrease Operating Lease Right Of Use Asset
IncreaseDecreaseOperatingLeaseRightOfUseAsset
-7002000 usd
CY2021 ruby Increase Decrease Operating Lease Right Of Use Asset
IncreaseDecreaseOperatingLeaseRightOfUseAsset
-5352000 usd
CY2020 ruby Increase Decrease Operating Lease Right Of Use Asset
IncreaseDecreaseOperatingLeaseRightOfUseAsset
-5539000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5000 usd
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-46000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9811000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5858000 usd
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1369000 usd
CY2022 ruby Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
-6615000 usd
CY2021 ruby Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
-816000 usd
CY2020 ruby Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
-96000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-135000 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-553000 usd
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
283000 usd
CY2022 ruby Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
-10704000 usd
CY2021 ruby Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
-4401000 usd
CY2020 ruby Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
-5283000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-150142000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-145122000 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-127648000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5304000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3649000 usd
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5497000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17943000 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
83626000 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
122671000 usd
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
83931000 usd
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
85000000 usd
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
228600000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12944000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
81351000 usd
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
100432000 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
188000000 usd
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
360000 usd
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
150000 usd
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2021 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2020 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
25000000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
75702000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
232000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10963000 usd
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1484000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-75470000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
198453000 usd
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26484000 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1989000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-212668000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
134682000 usd
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-732000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227583000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92901000 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93633000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14915000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227583000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92901000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
4387000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
5092000 usd
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3822000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
11565000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
7364000 usd
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
8486000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
317000 usd
CY2022 ruby Offering Costs And Issuance Costs Included In Accounts Payable And Accrued Expenses
OfferingCostsAndIssuanceCostsIncludedInAccountsPayableAndAccruedExpenses
0 usd
CY2021 ruby Offering Costs And Issuance Costs Included In Accounts Payable And Accrued Expenses
OfferingCostsAndIssuanceCostsIncludedInAccountsPayableAndAccruedExpenses
35000 usd
CY2020 ruby Offering Costs And Issuance Costs Included In Accounts Payable And Accrued Expenses
OfferingCostsAndIssuanceCostsIncludedInAccountsPayableAndAccruedExpenses
0 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
496000 usd
CY2022 ruby Lease Asset Derecognized Upon Lease Cancellation
LeaseAssetDerecognizedUponLeaseCancellation
78000 usd
CY2021 ruby Lease Asset Derecognized Upon Lease Cancellation
LeaseAssetDerecognizedUponLeaseCancellation
0 usd
CY2020 ruby Lease Asset Derecognized Upon Lease Cancellation
LeaseAssetDerecognizedUponLeaseCancellation
982000 usd
CY2022 ruby Proceeds From Stock Options Exercised In Other Current Assets
ProceedsFromStockOptionsExercisedInOtherCurrentAssets
25502000 usd
CY2021 ruby Proceeds From Stock Options Exercised In Other Current Assets
ProceedsFromStockOptionsExercisedInOtherCurrentAssets
0 usd
CY2020 ruby Proceeds From Stock Options Exercised In Other Current Assets
ProceedsFromStockOptionsExercisedInOtherCurrentAssets
0 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-856700000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14900000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-179700000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-150100000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the accrual of research and development expenses and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions.</span></div>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Concentrations of Credit Risk and of Significant Suppliers</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company’s cash and cash equivalents as of December 31, 2022 consisted of cash, money market accounts and U.S. government money market funds. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div>
CY2021Q4 ruby Restricted Cash For Benefit Of Landlord
RestrictedCashForBenefitOfLandlord
1700000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1600000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14900000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227600000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92900000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
100000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
1700000 usd
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
1700000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
570000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
69386000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
424000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17856000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
146000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51530000 usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
4070000 usd
CY2021Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
0 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6300000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7700000 usd
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5700000 usd
CY2022Q4 ruby Accrued Employee Termination Benefits Current
AccruedEmployeeTerminationBenefitsCurrent
1401000 usd
CY2021Q4 ruby Accrued Employee Termination Benefits Current
AccruedEmployeeTerminationBenefitsCurrent
0 usd
CY2022Q4 ruby Accrued Contract Termination Costs Current
AccruedContractTerminationCostsCurrent
1387000 usd
CY2021Q4 ruby Accrued Contract Termination Costs Current
AccruedContractTerminationCostsCurrent
0 usd
CY2022Q4 ruby Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
521000 usd
CY2021Q4 ruby Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
889000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7451000 usd
CY2022Q4 ruby Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
0 usd
CY2021Q4 ruby Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
2713000 usd
CY2022Q4 ruby Accrued Manufacturing Facility Expenses Current
AccruedManufacturingFacilityExpensesCurrent
0 usd
CY2021Q4 ruby Accrued Manufacturing Facility Expenses Current
AccruedManufacturingFacilityExpensesCurrent
2349000 usd
CY2022Q4 ruby Deposit For Assets Held For Sale Current
DepositForAssetsHeldForSaleCurrent
2125000 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1654000 usd
CY2021Q4 ruby Deposit For Assets Held For Sale Current
DepositForAssetsHeldForSaleCurrent
0 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
173000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
670000 usd
CY2022Q4 ruby Accrued Expenses And Other Current Liabilities Excluding Current Operating Lease Liabilities
AccruedExpensesAndOtherCurrentLiabilitiesExcludingCurrentOperatingLeaseLiabilities
5607000 usd
CY2021Q4 ruby Accrued Expenses And Other Current Liabilities Excluding Current Operating Lease Liabilities
AccruedExpensesAndOtherCurrentLiabilitiesExcludingCurrentOperatingLeaseLiabilities
14072000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0 usd
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
75000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q4 ruby Long Term Debt Net Of Current
LongTermDebtNetOfCurrent
0 usd
CY2021Q4 ruby Long Term Debt Net Of Current
LongTermDebtNetOfCurrent
75000000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
0 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
500000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
76154000 usd
CY2022 ruby Number Of Votes Per Share
NumberOfVotesPerShare
1 vote
CY2018Q3 ruby Aggregate Stock Shares Authorized
AggregateStockSharesAuthorized
160000000 shares
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0237
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0081
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0110
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.784
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.774
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.694
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M13D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y18D
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15783000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35610000 usd
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33665000 usd
CY2020 ruby Income Tax Benefits For Net Operating Losses Incurred
IncomeTaxBenefitsForNetOperatingLossesIncurred
0 usd
CY2021 ruby Income Tax Benefits For Net Operating Losses Incurred
IncomeTaxBenefitsForNetOperatingLossesIncurred
0 usd
CY2022 ruby Income Tax Benefits For Net Operating Losses Incurred
IncomeTaxBenefitsForNetOperatingLossesIncurred
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.060
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.062
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.053
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.064
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.016
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.016
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.004
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.316
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.340
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
159691000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
145990000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
45478000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
36161000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
105000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
2137000 usd
CY2022Q4 ruby Deferred Tax Assets Capitalized Intellectual Property Costs
DeferredTaxAssetsCapitalizedIntellectualPropertyCosts
2051000 usd
CY2021Q4 ruby Deferred Tax Assets Capitalized Intellectual Property Costs
DeferredTaxAssetsCapitalizedIntellectualPropertyCosts
1746000 usd
CY2022Q4 ruby Deferred Tax Assets Capitalized Research And Development Expense
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense
32007000 usd
CY2021Q4 ruby Deferred Tax Assets Capitalized Research And Development Expense
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense
86000 usd
CY2022Q4 ruby Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
301000 usd
CY2021Q4 ruby Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
10194000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
24454000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
21483000 usd
CY2022Q4 ruby Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
74000 usd
CY2021Q4 ruby Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
264161000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
217797000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
732000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
9590000 usd
CY2022Q4 ruby Deferred Tax Liabilities Depreciation And Other
DeferredTaxLiabilitiesDepreciationAndOther
0 usd
CY2021Q4 ruby Deferred Tax Liabilities Depreciation And Other
DeferredTaxLiabilitiesDepreciationAndOther
1500000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
732000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
11090000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
263429000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
206707000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
584800000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
583600000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
37200000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
547600000 usd
CY2022 ruby Deferred Tax Asset Increase Decrease Amount
DeferredTaxAssetIncreaseDecreaseAmount
46400000 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
206707000 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
139877000 usd
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85884000 usd
CY2022 ruby Valuation Allowance Deferred Tax Asset Decreases Recorded As Benefit To Income Tax Provision
ValuationAllowanceDeferredTaxAssetDecreasesRecordedAsBenefitToIncomeTaxProvision
0 usd
CY2021 ruby Valuation Allowance Deferred Tax Asset Decreases Recorded As Benefit To Income Tax Provision
ValuationAllowanceDeferredTaxAssetDecreasesRecordedAsBenefitToIncomeTaxProvision
0 usd
CY2020 ruby Valuation Allowance Deferred Tax Asset Decreases Recorded As Benefit To Income Tax Provision
ValuationAllowanceDeferredTaxAssetDecreasesRecordedAsBenefitToIncomeTaxProvision
0 usd
CY2022 ruby Valuation Allowance Deferred Tax Asset Increase In Income Tax Provision
ValuationAllowanceDeferredTaxAssetIncreaseInIncomeTaxProvision
56722000 usd
CY2021 ruby Valuation Allowance Deferred Tax Asset Increase In Income Tax Provision
ValuationAllowanceDeferredTaxAssetIncreaseInIncomeTaxProvision
66830000 usd
CY2020 ruby Valuation Allowance Deferred Tax Asset Increase In Income Tax Provision
ValuationAllowanceDeferredTaxAssetIncreaseInIncomeTaxProvision
53993000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
263429000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
206707000 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
139877000 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2018Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000 usd
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000 usd
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
800000 usd
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
24000 usd
CY2022Q4 ruby Number Of Operating Leases
NumberOfOperatingLeases
1 lease
CY2022 ruby Number Of Expiration Dates
NumberOfExpirationDates
2 date
CY2022 ruby Number Of Distinct Leased Spaces
NumberOfDistinctLeasedSpaces
2 property
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P8Y
CY2018Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
3800000 usd
CY2018Q1 ruby Operating Lease Base Rent Incremental Percentage
OperatingLeaseBaseRentIncrementalPercentage
0.03
CY2018Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P9Y
CY2018Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
2500000 usd
CY2018Q4 ruby Operating Lease Base Rent Incremental Percentage
OperatingLeaseBaseRentIncrementalPercentage
0.03
CY2022 ruby Number Of Distinct Leased Spaces
NumberOfDistinctLeasedSpaces
2 property
CY2022Q4 ruby Operating Lease Termination Payment
OperatingLeaseTerminationPayment
5900000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2700000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1100000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1100000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
0 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1100000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
12655000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
8173000 usd
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
9240000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
41000 usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90305463 shares
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
3058000 usd
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
3723000 usd
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
1916000 usd
CY2022 us-gaap Sublease Income
SubleaseIncome
0 usd
CY2021 us-gaap Sublease Income
SubleaseIncome
719000 usd
CY2020 us-gaap Sublease Income
SubleaseIncome
1017000 usd
CY2022 us-gaap Lease Cost
LeaseCost
15713000 usd
CY2021 us-gaap Lease Cost
LeaseCost
11218000 usd
CY2020 us-gaap Lease Cost
LeaseCost
10163000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2679000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
35095000 usd
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40447000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1100000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9015000 usd
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8945000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28291000 usd
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32762000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y29D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0760
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0760
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-179666000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-196547000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-167731000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90305463 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87950440 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87950440 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80624608 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80624608 shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.99
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.23
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.23
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.08
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.08
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14886911 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18290816 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16570124 shares
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
1387000 usd

Files In Submission

Name View Source Status
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
0001709401-23-000005-index-headers.html Edgar Link pending
0001709401-23-000005-index.html Edgar Link pending
0001709401-23-000005.txt Edgar Link pending
0001709401-23-000005-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ruby-20221231.htm Edgar Link pending
ruby-20221231.xsd Edgar Link pending
ruby-20221231x10kex211.htm Edgar Link pending
ruby-20221231x10kex311.htm Edgar Link pending
ruby-20221231x10kex312.htm Edgar Link pending
ruby-20221231x10kex321.htm Edgar Link pending
ruby-20221231_g1.jpg Edgar Link pending
Show.js Edgar Link pending
ruby-20221231_cal.xml Edgar Link unprocessable
ruby-20221231_def.xml Edgar Link unprocessable
ruby-20221231_lab.xml Edgar Link unprocessable
ruby-20221231_pre.xml Edgar Link unprocessable
ruby-20221231_htm.xml Edgar Link completed